“To help treat Kovid-19 patients and protect front-line health workers in India, the United States identified medical, rapid diagnostic test kits, ventilators, and personal protective equipment (PPE) supplies” That will be made available to India immediately. The United States is also pursuing options to provide oxygen production and related supplies on an urgent basis, “part of a call between the national security advisors of the two countries, In part.
The government reported 349,691 new cases on Saturday, the fourth consecutive day in the country, according to the government and scientist, setting a world record for daily infections.
During the call between US National Security Advisor Jake Sullivan and his Indian counterpart, Ajit Doval, Sullivan “expressed deep sympathy for the people of India after the recent spike in the Kovid-19 cases.”
“As India has sent aid to the United States because our hospitals were stressed early in the epidemic, the United States is determined to help India in its time of need,” the readout said.
The release stated that the US has “identified specific raw materials urgently needed for the Indian manufacture of the covalent vaccine that will be made immediately available to India.”
The White House also announced that the US Development Finance Corporation would “expand the vaccine manufacturer’s substantial capacity in India” 2022. “
According to White, an expert team of public health advisors from the US Embassy (CDC) and USAID will be dispatched to work closely with the staff of the US Embassy, India’s ministries of health and India’s epidemic intelligence service. House.
According to a source, National Security Council officials held meetings on weekends to assist the country and the Health and Human Services Department also did. In addition to oxygen and personal protective equipment, discussions have revolved around providing more vaccine components and materials for the administration of the vaccine.
Dr. Anthony Fauci described those discussions in an interview on ABC’s “This Week with George Stephanopolous” on Sunday, saying, “Right now, even as we speak, George is actually discussing that What we can do on the ground – oxygen supply, drugs, testing, PPE, as well as taking a look at intermediates and how these individuals can get the vaccine goes on for a long time. ”
But the latest statement from Biden’s National Security Advisor does not mention sharing the dose of the AstraZeneca vaccine, of which there are tens of millions of stockpiled in the US. With the exception of a few million sent to Canada and Mexico, the dose has gone unused, as AstraZeneca has not yet been granted emergency use authorization by the US Food and Drug Administration. The administration has faced pressure to release AstraZeneca vaccines in India. A person familiar with the matter said that the issue has come up in the meetings but the final decision is still going on.
Reacting to Kovid, senior White House adviser Andy Slavitt did not say Sunday whether the US was planning to send the vaccine to India.
“When we decide on what we’re going to do with the additional vaccines, about exporting them, we’ll announce them,” he told Pamela Brown of CNN on “Newsroom”. “We are evaluating all these options.”
In March, the US delivered approximately four million doses of AstraZeneca Kovid-19 to Mexico and Canada.
Fauci said in his interview that sending vaccines is a possibility. Currently, the CDC is consulting with the country and providing technical support.
“I think there’s going to be something that’s for active consideration,” he said. “We really need to do more. I don’t think you can walk away from it. And we are.”
Fauci told Reuters earlier this month that the American would not need the AstraZeneca vaccine, even if it was authorized for emergency use.
This story has been updated with additional Sunday events.